CEO Marc Miller was paid $16,148,937 in fiscal year 2025, ↑ up 7.5% from fiscal year 2024, the 67th percentile of its disclosed peer group (SEC filing 0001193125-26-148814 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$16,148,937 ↑ Marc Miller total, FY2025 | 67th CEO pay percentile vs peers | 283:1 CEO-to-median pay ratio | 99.63% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
UHS's next annual pay disclosure, estimated April 15, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Marc Miller | $1,430,769 | $0 | $9,999,904 | $0 | $4,292,307 | $84,369 | $341,588 | $16,148,937 |
| Chief Executive Officer, President and Director | ||||||||
| Alan Miller | 1,073,077 | 1,073,077 | 5,062,102 | 0 | 0 | 0 | 864,939 | 8,073,195 |
| Executive Chairman of the Board and Founder | ||||||||
| Steve Filton | 853,299 | 0 | 2,450,025 | 0 | 1,706,598 | 51,586 | 47,187 | 5,108,695 |
| Executive Vice President, Chief Financial Officer and Secretary | ||||||||
| Edward Sim | 802,024 | 0 | 2,290,465 | 0 | 1,604,048 | 48,416 | 20,036 | 4,764,989 |
| Executive Vice President, President of Acute Care Division | ||||||||
| Matthew Peterson | 719,971 | 0 | 2,012,660 | 0 | 1,353,545 | 43,526 | 46,735 | 4,176,437 |
| Executive Vice President, President of Behavioral Health Division | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Marc Miller | $16,148,937 | $15,021,836 | $14,407,937 | ↑ +1,127,101 |
| Alan Miller | 8,073,195 | 7,931,946 | 8,369,731 | ↑ +141,249 |
| Steve Filton | 5,108,695 | 5,002,133 | 4,650,157 | ↑ +106,562 |
| Edward Sim | 4,764,989 | 4,688,447 | 5,469,137 | ↑ +76,542 |
| Matthew Peterson | 4,176,437 | 4,173,981 | 4,049,604 | ↑ +2,456 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Universal Health Services's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper UHS reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses UHS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named UHS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Eileen C. McDonnell | Independent Director | $345,917 |
| Elliot J. Sussman | Independent Director | $353,417 |
| Maria R. Singer | Independent Director | $329,667 |
| Nina Chen-Langenmayr | Independent Director | $319,667 |
| Warren J. Nimetz | Independent Director | $300,917 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Warren J. Nimetz | Director | 2026-05-20 | A | 1,217 | $0 | $0 | Common | Form 4 ↗ |
| Maria R. Singer | Director | 2026-05-20 | A | 1,217 | 0 | 0 | Common | Form 4 ↗ |
| Eileen C. McDonnell | Director | 2026-05-20 | A | 1,217 | 0 | 0 | Common | Form 4 ↗ |
| Elliot J. Sussman | Director | 2026-05-20 | A | 1,217 | 0 | 0 | Common | Form 4 ↗ |
| Nina Chen-Langenmayr | Director | 2026-05-20 | A | 1,217 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 25,495 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 25,495 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 25,495 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 25,495 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 50,990 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 14,163 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 14,163 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 14,163 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 14,163 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 14,163 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 14,163 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 9,418 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 9,418 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 9,418 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 9,418 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 50,990 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | D | 13,963 | 0 | 0 | Common | Form 4 ↗ |
| Alan B. Miller | Director | 2026-05-27 | A | 13,963 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Marc D. Miller | PSU | 2025-03-19 | 28,077 | 42,116 | — | 4,999,952 | $7,500,017 |
| Alan B. Miller | PSU | 2025-03-19 | — | 14,213 | — | 2,531,051 | 2,531,051 |
| Edward Sim | RSU | 2025-03-19 | — | — | 6,431 | — | — |
| Marc D. Miller | PSU | 2025-03-19 | 28,077 | 4,292,307 | — | 4,999,952 | 4,999,952 |
| Alan B. Miller | PSU | 2025-03-19 | 14,213 | 21,320 | — | 2,531,051 | 3,796,666 |
| Steve Filton | RSU | 2025-03-19 | — | — | 6,879 | — | — |
| Edward Sim | PSU | 2025-03-19 | 3,216 | 6,431 | — | 9,647 | 1,145,232 |
| Steve Filton | PSU | 2025-03-19 | 3,440 | 6,879 | — | 10,319 | 1,225,012 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Marc D. Miller | $0 | $12,499,969 | $0 | 100.0% |
| Alan B. Miller | 0 | 6,327,717 | 0 | 100.0% |
| Edward Sim | 0 | 1,145,232 | 0 | 100.0% |
| Steve Filton | 0 | 1,225,012 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Edward Sim | RSU | 1,354 | — | $241,960 |
| Steve Filton | RSU | 14,069 | — | 2,361,542 |
| Miller | PSU | 29,068 | — | 4,879,193 |
| Matthew Peterson | RSU | 17,890 | — | 1,413,427 |
| Matthew Peterson | PSU | 11,558 | — | 1,940,065 |
| Miller | RSU | 562,313 | — | 52,799,962 |
| Miller | RSU | 219,220 | — | 18,746,576 |
| Miller | PSU | 55,276 | — | 9,278,314 |
Our compensation philosophy of strongly aligning pay with performance is grounded in best practices that are regulatory compliant, financially sound and provide long-term value to stockholders.
| CEO STI target (% of salary) | 150% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | — |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-20 | 62,219,230 | 228,600 | 1,996 | 99.63% | Passed |
| 2023 | 2023-05-17 | 63,345,551 | 640,071 | 3,382 | 99% | Passed |
| 2020 | 2020-05-20 | 58,722,749 | 6,471,435 | 3,695 | 90.07% | Passed |
| 2017 | 2017-05-17 | 63,627,444 | 2,465,273 | 2,922 | 96.27% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-20 | 99.63%a |
| 2023 | 2023-05-17 | 99%b |
| 2020 | 2020-05-20 | 90.07%c |
a. Approved under the standard stated in the filing — “An abstention from voting by a stockholder present in person or by proxy at the meeting has no effect on the outcome of the vote because an abstention does not count as a vote cast.”.
b. Approved under the standard stated in the filing — “An abstention from voting by a stockholder present in person or by proxy at the meeting has the same legal effect as a vote "against" the matter because it represents a share present or represented at the meeting and entitled to vote, thereby increasing the number of affirmative votes required to approve this proposal.”.
c. Approved under the standard stated in the filing — “Abstentions will be counted toward the tabulation of votes cast on this proposal and will have the same effect as a negative vote on this matter, while broker non-votes will have no effect on the outcome of the vote.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 283 : 1 |
|---|---|
| CEO total compensation | $16,148,937 |
| Median employee compensation | $57,048 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Elliot J. SussmanIndependent | $152,500 | $200,039 | $0 | $0 | $878 | $353,417 |
| Eileen C. McDonnellIndependent | 145,000 | 200,039 | 0 | 0 | 878 | 345,917 |
| Maria R. SingerIndependent | 128,750 | 200,039 | 0 | 0 | 878 | 329,667 |
| Nina Chen-LangenmayrIndependent | 118,750 | 200,039 | 0 | 0 | 878 | 319,667 |
| Warren J. NimetzIndependent | 100,000 | 200,039 | 0 | 0 | 878 | 300,917 |
| Alan B. MillerEmployee director · Board Chair · Executive (Chair) · Finance (Chair) | — | — | — | — | — | 0 |
| Marc D. MillerEmployee director · Executive · Finance | — | — | — | — | — | 0 |
| Annual cash retainer | $100,000 |
|---|---|
| Annual equity retainer | $200,039 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 15,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $645,000 |
| Equity awards (grant-date value) | $1,000,195 |
| All other compensation | $4,390 |
| Total cost of the board | $1,649,585 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Universal Health Services names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Universal Health Services.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Tenet Healthcare Corporation | 2025 | Saum Sutaria | $1,500,000 | $31,677,365 | $0 | $9,000,000 | $43,108,969 |
| 2 | HCA Healthcare, Inc. | 2025 | Samuel Hazen | 1,577,815 | 8,474,543 | 8,514,090 | 5,416,732 | 26,456,606 |
| 3 | Molina Healthcare, Inc. | 2025 | Joseph Zubretsky | 1,600,000 | 16,199,988 | 0 | 0 | 18,340,783 |
| 4 | DaVita, Inc. | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 5 | Universal Health Services | 2025 | Marc Miller | 1,430,769 | 9,999,904 | 0 | 4,292,307 | 16,148,937 |
| 6 | Quest Diagnostics Incorporated | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 7 | Henry Schein, Inc. | 2025 | Stanley Bergman | 1,707,000 | 7,764,800 | 0 | 2,289,251 | 12,013,915 |
| 8 | Encompass Health Corporation | 2025 | Mark Tarr | 1,100,000 | 5,285,381 | 1,165,376 | 2,581,525 | 10,297,258 |
| 9 | Acadia Healthcare Company, Inc. | 2025 | Suzanne Foster | 1,000,000 | 7,530,880 | 0 | 1,394,694 | 10,256,240 |
| 10 | Laboratory Corporation of America Holdings | 2025 | Michael Egholm | 680,256 | 5,337,883 | 1,671,363 | 1,120,000 | 8,823,502 |
| 11 | Brookdale Senior Living, Inc. | 2025 | Nikolas Stengle | 229,310 | 4,283,968 | 0 | 403,571 | 5,307,655 |
| 12 | Community Health Systems, Inc. | 2025 | Kevin Hammons | 927,194 | 812,700 | 204,300 | 1,746,642 | 4,772,869 |
| 13 | Select Medical Holdings Corporation | 2025 | Thomas Mullin | 618,000 | 1,425,000 | 0 | 939,360 | 3,042,527 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Universal Health Services | 200% | RSU 50 · PSU 50 | No | FW Cook |
| Acadia Healthcare Company, Inc. | 116.22% | PSU 50 · RSU 50 | Yes — Relative TSR | ClearBridge |
| Brookdale Senior Living, Inc. | 125.7% | not disclosed | No | F.W. Cook & Co., Inc. |
| Community Health Systems, Inc. | not disclosed | PSU 75 · Option 25 | not disclosed | Mercer |
| DaVita, Inc. | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| Encompass Health Corporation | 173.8% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| HCA Healthcare, Inc. | 195.78% | SAR 50 · PSU 50 | No | Semler Brossy |
| Henry Schein, Inc. | 89.3% | PSU 65 · RSU 35 | No | Pearl Meyer |
| Laboratory Corporation of America Holdings | 160% | not disclosed | not disclosed | Pearl Meyer |
| Molina Healthcare, Inc. | not disclosed | PSU 60 · RSU 40 | No | FW Cook |
| Quest Diagnostics Incorporated | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| Select Medical Holdings Corporation | 190% | RSU 100 | not disclosed | not disclosed |
| Tenet Healthcare Corporation | 200% | PSU 60 · RSU 40 | No | Meridian Compensation Partners, LLC |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Marc Miller | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Executive Compensation”. As printed: 16,148,937. Filing ↗machine: span 1326856–1326866 |
| 2 | Section 01, Alan Miller | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Executive Compensation”. As printed: 8,073,195. Filing ↗ |
| 3 | Section 01, Steve Filton | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Executive Compensation”. As printed: 5,108,695. Filing ↗machine: span 1400494–1400503 |
| 4 | Section 01, Edward Sim | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Executive Compensation”. As printed: 4,764,989. Filing ↗machine: span 1437395–1437404 |
| 5 | Section 01, Matthew Peterson | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Executive Compensation”. As printed: 4,176,437. Filing ↗machine: span 1474368–1474377 |
| 6 | Section 03, Marc D. Miller PSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t125 · r7 · c28 · span 1894007–1894016 |
| 7 | Section 03, Alan B. Miller PSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “GRANTS OF PLAN-BASED AWARDS” · grants of plan-based awards table. Filing ↗machine: t125 · r10 · c26 · span 1925147–1925156 |
| 8 | Section 03, Edward Sim RSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t101 · r6 · c2 · span 1157627–1157632 |
| 9 | Section 03, Marc D. Miller PSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “GRANTS OF PLAN-BASED AWARDS” · grants of plan-based awards table. Filing ↗machine: t125 · r5 · c28 · span 1870858–1870867 |
| 10 | Section 03, Alan B. Miller PSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t125 · r12 · c31 · span 1949264–1949273 |
| 11 | Section 03, Steve Filton RSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t101 · r5 · c2 · span 1151742–1151747 |
| 12 | Section 03, Edward Sim PSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “GRANTS OF PLAN-BASED AWARDS” · grants of plan-based awards table. Filing ↗machine: t125 · r20 · c26 · span 2035339–2035348 |
| 13 | Section 03, Steve Filton PSU | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “GRANTS OF PLAN-BASED AWARDS” · grants of plan-based awards table. Filing ↗machine: t125 · r15 · c26 · span 1980406–1980415 |
| 14 | Section 07, pay ratio | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “CEO Pay Ratio”. As printed: 283 : 1. Filing ↗ |
| 15 | Section 08, Elliot J. Sussman | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Director Compensation”. As printed: 353,417. Filing ↗machine: t164 · r12 · c23 · span 3545520–3545746 |
| 16 | Section 08, Eileen C. McDonnell | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Director Compensation”. As printed: 345,917. Filing ↗machine: t164 · r6 · c23 · span 3497118–3497344 |
| 17 | Section 08, Maria R. Singer | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Director Compensation”. As printed: 329,667. Filing ↗machine: t164 · r10 · c23 · span 3529381–3529607 |
| 18 | Section 08, Nina Chen-Langenmayr | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Director Compensation”. As printed: 319,667. Filing ↗machine: t164 · r4 · c23 · span 3480983–3481209 |
| 19 | Section 08, Warren J. Nimetz | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Director Compensation”. As printed: 300,917. Filing ↗machine: t164 · r8 · c23 · span 3513250–3513476 |
| 20 | Section 08, Alan B. Miller | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 21 | Section 08, Marc D. Miller | DEF 14A | 2026-04-09 | 0001193125-26-148814 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 22 | Section 02, Warren J. Nimetz 2026-05-20 | Form 4 | 2026-05-21 | 0000352915-26-000045 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Maria R. Singer 2026-05-20 | Form 4 | 2026-05-21 | 0000352915-26-000047 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Eileen C. McDonnell 2026-05-20 | Form 4 | 2026-05-21 | 0000352915-26-000051 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Elliot J. Sussman 2026-05-20 | Form 4 | 2026-05-21 | 0000352915-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Nina Chen-Langenmayr 2026-05-20 | Form 4 | 2026-05-21 | 0000352915-26-000056 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Alan B. Miller 2026-05-27 | Form 4 | 2026-05-29 | 0000352915-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 06, 2026 vote | Form 8-K | 2026-05-22 | 0001193125-26-235480 | Item 5.07 · say-on-pay result. As reported: 99.63% (votes for as printed: 62,219,230). Filing ↗ |
| 46 | Section 06, 2023 vote | Form 8-K | 2023-05-17 | 0000950170-23-022734 | Item 5.07 · say-on-pay result. As reported: 99% (votes for as printed: 63,345,551). Filing ↗ |
| 47 | Section 06, 2020 vote | Form 8-K | 2020-05-22 | 0001564590-20-026652 | Item 5.07 · say-on-pay result. As reported: 90.07%. Filing ↗ |
| 48 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 49 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 50 | Section 09b board cost (computed) | Computed | — | — | Cash 645,000 + equity 1,000,195 + all other 4,390 = 1,649,585, summed across the director compensation table rows.machine: formula: Σ = 1,649,585 |
| 51 | Tenet Healthcare Corporation, Section 10b CEO total | DEF 14A | 2026-04-16 | 0001193125-26-159118 | CEO total compensation as printed in Tenet Healthcare Corporation's own proxy. As printed: 43,108,969. Filing ↗machine: r4 · c34 · span 969343–969353 |
| 52 | HCA Healthcare, Inc., Section 10b CEO total | DEF 14A | 2026-03-13 | 0001193125-26-106142 | CEO total compensation as printed in HCA Healthcare, Inc.'s own proxy. As printed: 26,456,606. Filing ↗machine: span 784078–784088 |
| 53 | Molina Healthcare, Inc., Section 10b CEO total | DEF 14A | 2026-03-23 | 0001179929-26-000014 | CEO total compensation as printed in Molina Healthcare, Inc.'s own proxy. As printed: 18,340,783. Filing ↗machine: r3 · c21 · span 812138–812148 |
| 54 | DaVita, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0000927066-26-000053 | CEO total compensation as printed in DaVita, Inc.'s own proxy. As printed: 18,210,597. Filing ↗machine: r2 · c45 · span 800715–800725 |
| 55 | Universal Health Services (subject), Section 10b CEO total | DEF 14A | 2026-04-09 | 0001193125-26-148814 | CEO total compensation as printed in Universal Health Services's own proxy. As printed: 16,148,937. Filing ↗machine: span 1326856–1326866 |
| 56 | Quest Diagnostics Incorporated, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013356 | CEO total compensation as printed in Quest Diagnostics Incorporated's own proxy. As printed: 15,498,479. Filing ↗machine: r2 · c17 · span 699327–699337 |
| 57 | Henry Schein, Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001193125-26-146317 | CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. Filing ↗machine: t221 · r3 · c35 · span 671366–671376 |
| 58 | Encompass Health Corporation, Section 10b CEO total | DEF 14A | 2026-04-07 | 0000785161-26-000105 | CEO total compensation as printed in Encompass Health Corporation's own proxy. As printed: 10,297,258. Filing ↗machine: r2 · c48 · span 734470–734480 |
| 59 | Acadia Healthcare Company, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001628280-26-027965 | CEO total compensation as printed in Acadia Healthcare Company, Inc.'s own proxy. As printed: 10,256,240. Filing ↗machine: r2 · c48 · span 476441–476451 |
| 60 | Laboratory Corporation of America Holdings, Section 10b CEO total | DEF 14A | 2026-04-27 | 0001140361-26-017100 | CEO total compensation as printed in Laboratory Corporation of America Holdings's own proxy. As printed: 8,823,502. Filing ↗machine: r2 · c22 · span 553256–553266 |
| 61 | Brookdale Senior Living, Inc., Section 10b CEO total | DEF 14A | 2026-04-30 | 0001193125-26-197412 | CEO total compensation as printed in Brookdale Senior Living, Inc.'s own proxy. As printed: 5,307,655. Filing ↗machine: r4 · c27 · span 1161767–1161776 |
| 62 | Community Health Systems, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0001193125-26-140269 | CEO total compensation as printed in Community Health Systems, Inc.'s own proxy. As printed: 4,772,869. Filing ↗machine: r4 · c10 · span 1692996–1693005 |
| 63 | Select Medical Holdings Corporation, Section 10b CEO total | DEF 14A | 2026-03-04 | 0001104659-26-023205 | CEO total compensation as printed in Select Medical Holdings Corporation's own proxy. As printed: 3,042,527. Filing ↗machine: r13 · c41 · span 384685–384694 |
| 64 | Section 10a, Acadia Healthcare Company, Inc. reciprocity | DEF 14A | — | 0001628280-26-027965 | Acadia Healthcare Company, Inc.'s most recent proxy was read; its disclosed peer group does not include Universal Health Services. Filing ↗ |
| 65 | Section 10a, DaVita, Inc. reciprocity | DEF 14A | — | 0000927066-26-000053 | DaVita, Inc. names Universal Health Services in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 66 | Section 10a, Henry Schein, Inc. reciprocity | DEF 14A | — | 0001193125-26-146317 | Henry Schein, Inc. names Universal Health Services in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 67 | Section 10a, Molina Healthcare, Inc. reciprocity | DEF 14A | — | 0001179929-26-000014 | Molina Healthcare, Inc. names Universal Health Services in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 68 | Section 10a, Tenet Healthcare Corporation reciprocity | DEF 14A | — | 0001193125-26-159118 | Tenet Healthcare Corporation names Universal Health Services in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 69 | Section 10a, Brookdale Senior Living, Inc. reciprocity | DEF 14A | — | 0001193125-26-197412 | Brookdale Senior Living, Inc. names Universal Health Services in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 70 | Section 10a, Community Health Systems, Inc. reciprocity | DEF 14A | — | 0001193125-26-140269 | Community Health Systems, Inc. names Universal Health Services in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 71 | Section 10a, Encompass Health Corporation reciprocity | DEF 14A | — | 0000785161-26-000105 | Encompass Health Corporation names Universal Health Services in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 72 | Section 10a, HCA Healthcare, Inc. reciprocity | DEF 14A | — | 0001193125-26-106142 | HCA Healthcare, Inc.'s most recent proxy was read; its disclosed peer group does not include Universal Health Services. Filing ↗ |
| 73 | Section 10a, Laboratory Corporation of America Holdings reciprocity | DEF 14A | — | 0001140361-26-017100 | Laboratory Corporation of America Holdings's most recent proxy was read; its disclosed peer group does not include Universal Health Services. Filing ↗ |
| 74 | Section 10a, Quest Diagnostics Incorporated reciprocity | DEF 14A | — | 0001140361-26-013356 | Quest Diagnostics Incorporated's most recent proxy was read; its disclosed peer group does not include Universal Health Services. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.